 |
|
|
|||||
America's drug supply faces a serious threat from China's increasing control. A US commission warns that a quarter of generic drugs rely on Chinese ingredients. This dependency could lead to severe shortages and impact healthcare. China is also expanding its influence in innovative drug development. The US is exploring ways to reduce this reliance and bolster domestic manufacturing.
Category:
News and Media
India's Q2 earnings season showed cautious optimism with decent results despite tariff concerns. Corporate capex revival and potential rate cuts are influencing investors, while autos, healthcare, and engineering sectors present attractive opportunities. The market is currently tactical, but sustained trends in healthcare, smaller banks, and autos suggest a potential shift towards broader market strength.
Category:
News and Media
Bitcoin has fallen below ninety thousand dollars for the first time in seven months. This drop indicates a decline in investor willingness to take risks across financial markets. Doubts about future U.S. interest rate cuts and broader market jitters are impacting cryptocurrencies. Major crypto players and technology shares are also experiencing pressure. This trend could signal wider market movements.
Category:
News and Media
Foreign institutional investors reduced stakes in several Indian defence stocks during the September quarter, citing valuation concerns and slower-than-expected order inflows. Despite this pullback, mutual funds showed increased buying interest, indicating a selective shift in investor preference within the sector.
Category:
News and Media
Aviva India's CIO Balamurugan Shanmugam discusses market volatility driven by tariff uncertainties and offers insights into the earnings landscape post Q2. He highlights that while domestic investors remain active, Aviva is sidestepping the soaring IPO valuations, believing the secondary market presents better long-term opportunities.
Category:
News and Media
Sites : [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] next »